2022 Mar 4
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA
Breaking the barriers to remyelination in multiple sclerosis
https://pubmed.ncbi.nlm.nih.gov/35255453/
Abstract
Chronically demyelinated axons are rendered susceptible to degeneration through loss of trophic support from oligodendrocytes and myelin, and this process underlies disability progression in multiple sclerosis. Promoting remyelination is a promising neuroprotective therapeutic strategy, but to date, has not been achieved through simply promoting oligodendrocyte precursor cell differentiation, and it is clear that a detailed understanding of the molecular mechanisms underlying failed remyelination is required to guide future therapeutic approaches. In multiple sclerosis, remyelination is impaired by extrinsic inhibitory cues in the lesion microenvironment including secreted effector molecules released from compartmentalized immune cells and reactive glia, as well as by intrinsic defects in oligodendrocyte lineage cells, most notably increased metabolic demands causing oxidative stress and accelerated cellular senescence. Promising advances in our understanding of the cellular and molecular mechanisms underlying these processes offers hope for strategically designed interventions to facilitate remyelination thereby resulting in robust clinical benefits.
Remyelination
Re: Remyelination
https://www.eboro.cz
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1235 Views
-
Last post by DIM
-
- 0 Replies
- 1038 Views
-
Last post by frodo
-
- 0 Replies
- 1114 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1254 Views
-
Last post by NHE
-
- 0 Replies
- 1085 Views
-
Last post by frodo
-
- 1 Replies
- 2885 Views
-
Last post by Tif
-
- 0 Replies
- 1362 Views
-
Last post by DIM
-
- 0 Replies
- 1427 Views
-
Last post by DIM
-
- 0 Replies
- 1752 Views
-
Last post by DIM